Ionis Pharmaceuticals, Inc. (IONS) Gross margin 2016–2025
Ionis Pharmaceuticals, Inc. (IONS) gross margin by fiscal year — reported gross profit divided by reported revenue.
98.3%FY2025 · since FY2016: 100.0% → 98.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 98.3% | -0.1 pp |
| FY2024 | 98.4% | -0.4 pp |
| FY2023 | 98.8% | +1.2 pp |
| FY2022 | 97.6% | -1.1 pp |
| FY2021 | 98.7% | +0.3 pp |
| FY2020 | 98.4% | -1.2 pp |
| FY2019 | 99.6% | -0.1 pp |
| FY2018 | 99.7% | -0.3 pp |
| FY2017 | 100.0% | +0.0 pp |
| FY2016 | 100.0% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More IONS financial trends
IONS RevenueIONS Net incomeIONS Net marginIONS Gross profitIONS Operating incomeIONS Operating marginIONS Operating cash flowIONS Free cash flowIONS Capital expendituresIONS Return on equityIONS Stock buybacksIONS Dividends paidIONS Total assetsIONS Total liabilitiesIONS Shareholders’ equityIONS overview →